Skip to main content

Advertisement

SpringerLink
Log in

Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

To investigate the relationship between glycopeptide use and decreased susceptibility to teicoplanin in coagulase-negative staphylococci (CNS) isolates, data on teicoplanin susceptibility and glycopeptide use from existing microbiology laboratory and pharmacy databases were collected for the period between July 2000 and March 2001. Pooled data for the entire study period were first used to analyse associations. Univariate analysis showed that the incidence of CNS with decreased susceptibility to teicoplanin was significantly correlated with the use of glycopetides, particularly with vancomycin use. This association was confirmed by multivariate analysis. This study suggests that variations in antimicrobial resistance are related to variations in antimicrobial use in the model of CNS with decreased susceptibility to teicoplanin, thus confirming the usefulness of restricting antimicrobial prescribing as a means of controlling resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Archer GL (1990) Staphylococcus epidermidis and other coagulase-negative staphylococci. In: Mandell GL, Douglas RG, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 1511–1518

  2. Pfaller MA, Herwaldt LA (1988) Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1:281–299

    CAS  PubMed  Google Scholar 

  3. Archer GL, Climo MW (1994) Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 38:2231–2237

    CAS  PubMed  Google Scholar 

  4. Karchmer AW, Archer GL, Dismukes WE (1983) Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 98:447–455

    Google Scholar 

  5. Grant AC, Lacey RW, Brownjohn AM, Turney JH (1986) Teicoplanin-resistant coagulase-negative staphylococcus. Lancet 2:1166–1167

    Article  CAS  PubMed  Google Scholar 

  6. Goldstein FW, Coutrot A, Sieffer A, Acar JF (1990) Percentages and distribution of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother 34:899–900

    CAS  PubMed  Google Scholar 

  7. Wilson AP, O’Hare MD, Felmingham D, Grüneberg RN (1986) Teicoplanin-resistant coagulase-negative staphylococcus. Lancet 2:973

    Article  CAS  PubMed  Google Scholar 

  8. Murphy OM, Stewart D, Gray J, Bint AJ (1996) Susceptibility of staphylococci to teicoplanin and vancomycin. J Antimicrob Chemother 38:316–317

    CAS  PubMed  Google Scholar 

  9. McGowan JE Jr (1983) Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 5:1033–1048

    PubMed  Google Scholar 

  10. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. J Am Med Assoc 275:234–240

    Article  CAS  Google Scholar 

  11. Lang S, Livesley MA, Lambert PA, Elliott J, Elliott TS (1999) The genomic diversity of coagulase-negative staphylococci associated with nosocomial infections. J Hosp Infect 43:187–193

    CAS  PubMed  Google Scholar 

  12. Tacconelli E, Tumbarello M, de Gaetano Donati K, Bettio M, Spanu T, Leone F, Sechi LA, Zanetti S, Fadda G, Cauda R (2001) Glycopeptide resistance among coagulase-negative staphylococci and clinical findings from a case-control study. Clin Infect Dis 33:1628–1635

    CAS  PubMed  Google Scholar 

  13. Soussy CJ, Carret G, Cavallo JD (2000) Antibiogram Committee of the French Microbiology Society. Report 2000–2001. Pathol Biol 48:832–871

    CAS  PubMed  Google Scholar 

  14. Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW (1998) Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 17:20–24

    CAS  PubMed  Google Scholar 

  15. Lesch CA, Itokasu GS, Danziger LH, Weinstein RA (2001) Multi-hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis 41:149–154

    Article  CAS  PubMed  Google Scholar 

  16. Lallemand S, Thouverez M, Boisson K, Talon D, Bertrand X (2002) Bacteremia caused by coagulase-negative staphylococci exhibiting decreased susceptibility to teicoplanin. J Hosp Infect 51:207–214

    Article  CAS  PubMed  Google Scholar 

  17. Boisson K, Bertin M, Thouverez M, Talon D, Bertrand X (2002) Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides and molecular epidemiology. Eur J Clin Microbiol Infect Dis 21:660–665

    Article  CAS  PubMed  Google Scholar 

  18. Cercenado E, Garcia-Leoni ME, Diaz MD, Sanchez-Carrillo C, Catalan P, De Quiros JC, Bouza E (1996) Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol 34:1765–1768

    CAS  PubMed  Google Scholar 

  19. Del’Alamo L, Cereda RF, Tosin I, Miranda EA, Sader HF (1999) Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagn Microbiol Infect Dis 34:185–191

    CAS  PubMed  Google Scholar 

  20. White RL, Friedrich LV, Mihm LB, Bosso JA (2000) Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas. Clin Infect Dis 31:16–23

    Article  CAS  PubMed  Google Scholar 

  21. Schimpff SC, Gaya H, Klastersky J, Tattersall MH, Zinner SH (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC International Antimicrobial Therapy Project Group. J Infect Dis 137:14–29

    CAS  PubMed  Google Scholar 

  22. Lopez-Lozano JM, Monnet DL, Yague A, Burgos A, Gonzalo N, Campillos P, Saez M (2000) Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 14:21–31

    Article  CAS  PubMed  Google Scholar 

  23. Monnet DL, Lopez-Lozano JM, Campillos P, Burgos A, Yague A, Gonzalo N (2001) Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect 7(Suppl 7):S29–S36

    Article  Google Scholar 

  24. Spanik S, Trupl J, Studena M, Kremery V (1997) Breakthrough nosocomial bacteraemia due to teicoplanin-resistant Staphylococcus haemolyticus in five patients with acute leukaemia. J Hosp Infect 35:155–159

    CAS  PubMed  Google Scholar 

  25. Sloos JH, van de Klundert JAM, Dijkshoorn L, van Boven CPA (1998) Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. J Antimicrob Chemother 42:787–791

    Google Scholar 

  26. Biavasco F, Giovanetti E, Montanari MP, Lupidi R, Varaldo PE (1991) Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J Antimicrob Chemother 27:71–79

    CAS  PubMed  Google Scholar 

  27. Cercenado E, Garcia-Leoni ME, Diaz MD, Sanchez-Carrillo C, Catalan P, De Quiros JC, Bouza E (1996) Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol 34:1765–1768

    CAS  PubMed  Google Scholar 

  28. Wong SSY, Ho PL, Woo PCY, Yuen KY (1999) Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 29:760–767

    CAS  PubMed  Google Scholar 

  29. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE Jr, Gaynes RP, the Intensive Care Antimicrobial Resistance Epidemiology Project and the National Nosocomial Infections Surveillance System Hospitals (1998) Antimicrobial use and resistance in eight U.S. hospitals: complexities of analysis and modelling. Infect Control Hosp Epidemiol 19:388–394

    CAS  PubMed  Google Scholar 

  30. Crowcroft NS, Ronveaux O, Monnet DL, Mertens R (1999) Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 20:31–36

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Institut SmithKline Beecham for supporting this program of clinical research, entitled “Correlation Between Antibiotic Use and Resistance”.

Author information

Authors and Affiliations

  1. Service d’Hygiène Hospitalière et d’Epidémiologie Moléculaire, CHU Jean Minjoz, 25030, Besançon Cedex, France

    M. Bertin, A. Muller, X. Bertrand, M. Thouverez & D. Talon

  2. Pharmacie Centrale, CHU Besançon, 25030, Besançon Cedex, France

    C. Cornette

Authors
  1. M. Bertin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Muller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X. Bertrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Cornette
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Thouverez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Talon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Talon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertin, M., Muller, A., Bertrand, X. et al. Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 23, 375–379 (2004). https://doi.org/10.1007/s10096-004-1129-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-004-1129-1

Keywords

Search

Navigation